United States - English - NLM (National Library of Medicine)

elanco us inc. - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomicalm tablets are to be used as part of a comprehensive behavioral management program to treat separation anxiety in dogs greater than 6 months of age. inappropriate barking or destructive behavior, as well as inappropriate elimination (urination or defecation) may be alleviated by the use of clomicalm tablets in conjunction with behavior modification. separation anxiety is a complex behavior disorder displayed when the owner (or other attachment figure) leaves the dog. the signs of separation anxiety evaluated in controlled trials were vocalization, destructive behavior, excessive salivation, and inappropriate elimination. in the absence of the owner or attachment figure, dogs with separation anxiety may exhibit one or more of these clinical signs. although the owner (attachment figure) may inadvertently misinterpret this behavior, which only happens in their absence, as spiteful, it is thought to be the result of anxiety experienced by the dog. punishment is not considered appropriate for a dog with sep

United States - English - NLM (National Library of Medicine)

virbac ah, inc. - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomicalm tablets are contraindicated in dogs with known hypersensitivity to clomipramine or other tricyclic antidepressants. clomicalm tablets should not be used in male breeding dogs. testicular hypoplasia was seen in dogs treated for 1 year at 12.5 times the maximum daily dose. clomicalm tablets should not be given in combination, or within 14 days before or after treatment with a monoamine oxidase inhibitor [e.g., selegiline hydrochloride (l-deprenyl), amitraz]. clomicalm tablets are contraindicated for use in dogs with a history of seizures or concomitantly with drugs which lower the seizure threshold.

European Union - English - EMA (European Medicines Agency)

virbac s.a. - clomipramine hydrochloride - psychoanaleptics - dogs - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.

New Zealand - English - Ministry for Primary Industries

virbac new zealand limited - clomipramine hydrochloride - clomipramine hydrochloride 41.67 g/kg - behaviour modifier

New Zealand - English - Ministry for Primary Industries

virbac new zealand limited - clomipramine hydrochloride - clomipramine hydrochloride 111 g/kg - analgesic

New Zealand - English - Ministry for Primary Industries

virbac new zealand limited - clomipramine hydrochloride - clomipramine hydrochloride 228.57 g/kg - behaviour modifier

United States - English - NLM (National Library of Medicine)

novartis animal health us, inc. - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomipramine hydrochloride 5 mg

Canada - English - Health Canada

virbac ah, inc. - clomipramine hydrochloride - tablet - 80mg - clomipramine hydrochloride 80mg - dogs

Canada - English - Health Canada

virbac ah, inc. - clomipramine hydrochloride - tablet - 20mg - clomipramine hydrochloride 20mg - dogs

Canada - English - Health Canada

virbac ah, inc. - clomipramine hydrochloride - tablet - 5mg - clomipramine hydrochloride 5mg - dogs